Pharming receives positive recommendation from NICE for Joenja(leniolisib) as a treatment for APDS
For media and investors only Joenja® is the first and only medicine…
RISA Labs Raises $3.5M to Eliminate Treatment Delays with AI-Powered Workflow Automation in Oncology
Palo Alto, April 17, 2025 (GLOBE NEWSWIRE) -- Cancer patients don’t just…
Endometriosis Awareness Month: Manipal Hospital Old Airport Road Hosts Expert Session on Diagnosis & Treatment
BANGALORE, India, April 14, 2025 /PRNewswire/ -- In India, menstrual pain is often…
NMD Pharma presents preclinical data highlighting increased innervation of skeletal muscle with ClC-1 ion channel inhibition treatment in neuromuscular disease model
Company presented clinical and preclinical data at the MDA Conference last week…
Recovery First Treatment Centers New Executive Director Pledges to Expand Access, Strengthen Addiction Treatment Services
HOLLYWOOD, Fla., March 24, 2025 (GLOBE NEWSWIRE) -- As the overdose crisis…
Novartis receives third FDA approval for oral Fabhalta (iptacopan) the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first…
Oxford BioTherapeutics Enters into a Strategic Collaboration with Roche to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer
March 19, 2025 04:00 ET | Source: Oxford BioTherapeutics Collaboration leverages OBT’s…
NeuroOne CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Todays Marketplace
EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies…
Capricor Therapeutics Announces Positive Data Demonstrating Long-Term Efficacy of Deramiocel for the Treatment of Duchenne Muscular Dystrophy
March 17, 2025 09:25 ET | Source: Capricor Therapeutics --Preservation of Skeletal…
Mineralys Therapeutics Announces Positive Topline Results from Launch-HTN and Advance-HTN Pivotal Trials of Lorundrostat for the Treatment of Uncontrolled or Resistant Hypertension
– Launch-HTN met its primary endpoint with lorundrostat 50 mg dose achieving…